Literature DB >> 9299401

Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease.

K I Pfrepper1, M Löchelt, M Schnölzer, R M Flügel.   

Abstract

The human foamy virus (HFV) protease (PR) was cloned into a modified thioredoxin fusion vector that carried a His-tag in the centrally located surface loop of the E. coli trxA protein, bacterially expressed as a soluble fusion protein, and subsequently purified by affinity chromatography. By using HFV Gag protein substrates, the purified recombinant HFV PR was enzymatically active whereas the corresponding active site PR mutant Asp/Ala was inactive. Incubation of synthetic peptides containing residues that flank the putative cleavage site with the recombinant HFV PR and subsequent matrix-assisted laser desorption ionization mass spectrometry of the cleavage products identified the proteolytic processing site of the HFV Gag precursor p74 and revealed that the peptide sequence RAVNTVTQ was cleaved between the Asn and Thr bond.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299401     DOI: 10.1006/bbrc.1997.7187

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions.

Authors:  Eun-Gyung Lee; Maxine L Linial
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

Review 3.  Foamy viruses are unconventional retroviruses.

Authors:  M L Linial
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.

Authors:  K I Pfrepper; M Löchelt; H R Rackwitz; M Schnölzer; H Heid; R M Flügel
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Genetic characterization of simian foamy viruses infecting humans.

Authors:  Réjane Rua; Edouard Betsem; Sara Calattini; Ali Saib; Antoine Gessain
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

6.  Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase.

Authors:  K I Pfrepper; J Reed; H R Rackwitz; M Schnölzer; R M Flügel
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.332

7.  Foamy virus particle formation.

Authors:  N Fischer; M Heinkelein; D Lindemann; J Enssle; C Baum; E Werder; H Zentgraf; J G Müller; A Rethwilm
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Isolation and characterization of an equine foamy virus.

Authors:  J Tobaly-Tapiero; P Bittoun; M Neves; M C Guillemin; C H Lecellier; F Puvion-Dutilleul; B Gicquel; S Zientara; M L Giron; H de Thé; A Saïb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease.

Authors:  K I Pfrepper; H R Rackwitz; M Schnölzer; H Heid; M Löchelt; R M Flügel
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Restriction of foamy viruses by primate Trim5alpha.

Authors:  Melvyn W Yap; Dirk Lindemann; Nicole Stanke; Juliane Reh; Dana Westphal; Helmut Hanenberg; Sadayuki Ohkura; Jonathan P Stoye
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.